The results presented in Figure 1A show a significant downregulation of the TIM-3 expression among all the B-ALL patients compared to the non-malignant healthy controls (FC = −1.058 ± 0.3548, p = 0.0061). This evidence concerns the gene HAVCR2 and acute lymphoblastic leukemia.